Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Deodhar

Showing results (41-50 of 272) with videos related to

Pageof 28
Sort By:
Current Opinion in Rheumatology|May 3, 2019
Harnessing the power of social media: how can it help in axial spondyloarthritis research?Katja Reuter, Abhijeet Danve, Atul Deodhar
Immunotherapy|September 19, 2019
Ixekizumab for treating ankylosing spondylitisSonam Kiwalkar, Secia Beier, Atul Deodhar
Expert Review of Clinical Immunology|February 14, 2022
Tofacitinib for the treatment of active ankylosing spondylitis in adultsRaagav Mohanakrishnan, Secia Beier, Atul Deodhar
Chinese Medical Journal|October 1, 2021
Coxitis in axial spondyloarthritis: the unmeasured, yet functionally most important, radiographic progressionFrancisco Airton Castro Rocha, Atul Deodhar
Expert Opinion on Biological Therapy|June 7, 2021
IL-23 inhibition for the treatment of psoriatic arthritisRaagav Mohanakrishnan, Secia Beier, Atul Deodhar
Clinical Rheumatology|May 11, 2023
Correction to: Difficult to treat psoriatic arthritis - how should we manage?Anand Kumthekar, Maedeh Ashrafi, Atul Deodhar
Best Practice & Research. Clinical Rheumatology|December 10, 2014
PrefaceAtul Deodhar, Filip van den Bosch
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Treatment of spondyloarthritis beyond TNF-alpha blockadeFilip Van den Bosch, Atul Deodhar
Autoimmunity Reviews|November 8, 2017
Is undifferentiated spondyloarthritis a discrete entity? A debateAtul Deodhar, Pierre Miossec, Xenofon Baraliakos
ACR Open Rheumatology|May 24, 2023
Human Leukocyte Antigen B27-Negative Axial Spondyloarthritis: What Do We Know?Atul Deodhar, Tejpal Gill, Marina Magrey
Pageof 28

Showing results (41-50 of 272) with videos related to

Sort By:
Pageof 28
Current Opinion in Rheumatology|May 3, 2019
Harnessing the power of social media: how can it help in axial spondyloarthritis research?Katja Reuter, Abhijeet Danve, Atul Deodhar
Immunotherapy|September 19, 2019
Ixekizumab for treating ankylosing spondylitisSonam Kiwalkar, Secia Beier, Atul Deodhar
Expert Review of Clinical Immunology|February 14, 2022
Tofacitinib for the treatment of active ankylosing spondylitis in adultsRaagav Mohanakrishnan, Secia Beier, Atul Deodhar
Chinese Medical Journal|October 1, 2021
Coxitis in axial spondyloarthritis: the unmeasured, yet functionally most important, radiographic progressionFrancisco Airton Castro Rocha, Atul Deodhar
Expert Opinion on Biological Therapy|June 7, 2021
IL-23 inhibition for the treatment of psoriatic arthritisRaagav Mohanakrishnan, Secia Beier, Atul Deodhar
Clinical Rheumatology|May 11, 2023
Correction to: Difficult to treat psoriatic arthritis - how should we manage?Anand Kumthekar, Maedeh Ashrafi, Atul Deodhar
Best Practice & Research. Clinical Rheumatology|December 10, 2014
PrefaceAtul Deodhar, Filip van den Bosch
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Treatment of spondyloarthritis beyond TNF-alpha blockadeFilip Van den Bosch, Atul Deodhar
Autoimmunity Reviews|November 8, 2017
Is undifferentiated spondyloarthritis a discrete entity? A debateAtul Deodhar, Pierre Miossec, Xenofon Baraliakos
ACR Open Rheumatology|May 24, 2023
Human Leukocyte Antigen B27-Negative Axial Spondyloarthritis: What Do We Know?Atul Deodhar, Tejpal Gill, Marina Magrey
Pageof 28